{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:34:57Z","timestamp":1792784097024,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903302"],"award-info":[{"award-number":["81903302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Elite Scientists Sponsorship Program by China Association for Science and Technology","award":["YESS20200151"],"award-info":[{"award-number":["YESS20200151"]}],"id":[{"id":"https:\/\/ror.org\/035vmht26","id-type":"ROR","asserted-by":"crossref"}]},{"name":"345 Talent Project of Shengjing Hospital of China Medical University","award":["M0294"],"award-info":[{"award-number":["M0294"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11892-023-01506-2","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:03:20Z","timestamp":1682485400000},"page":"103-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"23","author":[{"given":"Jinguo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanji","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-1592","authenticated-orcid":false,"given":"Yang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"1506_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183: 109119.","journal-title":"Diabetes Res Clin Pract"},{"key":"1506_CR2","volume-title":"IDF Diabetes Atlas","author":"DJBE Magliano","year":"2021","unstructured":"Magliano DJBE. IDF Diabetes Atlas. Brussels: International Diabetes Federation; 2021."},{"key":"1506_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8\u201314.","journal-title":"Int J Cardiol"},{"issue":"6","key":"1506_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","volume":"71","author":"M Chen-Xu","year":"2019","unstructured":"Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007\u20132016. Arthritis Rheumatol. 2019;71(6):991\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1506_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jsps.2022.04.013","volume":"30","author":"T Nutmakul","year":"2022","unstructured":"Nutmakul T. A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharm J. 2022;30(7):918\u201326.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"1506_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/art.38918","volume":"67","author":"SC Kim","year":"2015","unstructured":"Kim SC, Liu J, Solomon DH. Risk of incident diabetes in patients with gout: a cohort study. Arthritis Rheumatol. 2015;67(1):273\u201380.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1506_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12020-011-9449-2","volume":"40","author":"T Wang","year":"2011","unstructured":"Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine. 2011;40(1):109\u201316.","journal-title":"Endocrine"},{"issue":"10","key":"1506_CR8","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","volume":"47","author":"HK Choi","year":"2008","unstructured":"Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford). 2008;47(10):1567\u201370.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1506_CR9","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.amjmed.2016.06.041","volume":"129","author":"YC Tung","year":"2016","unstructured":"Tung YC, Lee SS, Tsai WC, Lin GT, Chang HW, Tu HP. Association Between Gout and Incident Type 2 Diabetes Mellitus: A Retrospective Cohort Study. Am J Med. 2016;129(11):e17\u201325.","journal-title":"Am J Med"},{"issue":"8","key":"1506_CR10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13548506.2019.1707241","volume":"25","author":"R Zhao","year":"2020","unstructured":"\u2022\u2022 Zhao R, Wang Y, Fu T, Zhou W, Ge X, Sha X, et al. Gout and risk of diabetes mellitus: meta-analysis of observational studies. Psychol Health Med. 2020;25(8):917\u201330. A meta-analysis discussing the prevalence of diabetes among patients with gout.","journal-title":"Psychol Health Med"},{"key":"1506_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12891-015-0762-4","volume":"16","author":"A Chhana","year":"2015","unstructured":"Chhana A, Lee G, Dalbeth N. Factors influencing the crystallization of monosodium urate: a systematic literature review. BMC Musculoskelet Disord. 2015;16:296.","journal-title":"BMC Musculoskelet Disord"},{"key":"1506_CR12","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 2000; 283(15): 2008\u201312.","DOI":"10.1001\/jama.283.15.2008"},{"key":"1506_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2288-6-31","volume":"6","author":"J Zamora","year":"2006","unstructured":"Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.","journal-title":"BMC Med Res Methodol"},{"issue":"7414","key":"1506_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"8","key":"1506_CR15","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s10067-018-4110-6","volume":"37","author":"S Stewart","year":"2018","unstructured":"Stewart S, Rome K, Eason A, House ME, Horne A, Doyle AJ, et al. Predictors of activity limitation in people with gout: a prospective study. Clin Rheumatol. 2018;37(8):2213\u20139.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1506_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2\u201310.","journal-title":"J Evid Based Med"},{"issue":"9","key":"1506_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10067-006-0527-4","volume":"26","author":"SY Chen","year":"2007","unstructured":"Chen SY, Chen CL, Shen ML. Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol. 2007;26(9):1453\u20137.","journal-title":"Clin Rheumatol"},{"key":"1506_CR18","doi-asserted-by":"crossref","unstructured":"Chua CG, Thong BY. Inflammatory Arthritis Among Military Servicemen From a Rheumatology Center in Singapore. Mil Med 2021.","DOI":"10.1093\/milmed\/usab246"},{"issue":"9","key":"1506_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ejim.2015.06.001","volume":"26","author":"CY Hsu","year":"2015","unstructured":"Hsu CY, Lin CL, Kao CH. Gout is associated with organic and psychogenic erectile dysfunction. Eur J Intern Med. 2015;26(9):691\u20135.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"1506_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jbspin.2015.12.003","volume":"84","author":"HJ Janssens","year":"2017","unstructured":"Janssens HJ, Arts PG, Schalk BW, Biermans MC. Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study. Joint Bone Spine. 2017;84(1):59\u201364.","journal-title":"Joint Bone Spine"},{"issue":"5","key":"1506_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3346\/jkms.2014.29.5.657","volume":"29","author":"K Joo","year":"2014","unstructured":"Joo K, Kwon SR, Lim MJ, Jung KH, Joo H, Park W. Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. J Korean Med Sci. 2014;29(5):657\u201361.","journal-title":"J Korean Med Sci"},{"key":"1506_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2474-12-103","volume":"12","author":"P Primatesta","year":"2011","unstructured":"Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskelet Disord. 2011;12:103.","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"1506_CR23","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/rheumatology\/keg422","volume":"42","author":"SY Chen","year":"2003","unstructured":"Chen SY, Chen CL, Shen ML, Kamatani N. Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford). 2003;42(12):1529\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1506_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12902-020-00560-1","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Cheng J, Chen Y, Wang N, Xia F, Chen C, et al. Association between serum vitamin D and uric acid in the eastern Chinese population: a population-based cross-sectional study. BMC Endocr Disord. 2020;20(1):79.","journal-title":"BMC Endocr Disord"},{"issue":"1089","key":"1506_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/postgradmedj-2015-133691","volume":"92","author":"A Collier","year":"2016","unstructured":"Collier A, Stirling A, Cameron L, Hair M, Crosbie D. Gout and diabetes: a common combination. Postgrad Med J. 2016;92(1089):372\u20138.","journal-title":"Postgrad Med J"},{"key":"1506_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/PROM.S8310","volume":"2010","author":"JD Hirsch","year":"2010","unstructured":"Hirsch JD, Terkeltaub R, Khanna D, Singh J, Sarkin A, Shieh M, et al. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas. 2010;2010:1\u20138.","journal-title":"Patient Relat Outcome Meas"},{"issue":"51","key":"1506_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002140","volume":"94","author":"CC Huang","year":"2015","unstructured":"Huang CC, Huang PH, Chen JH, Lan JL, Tsay GJ, Lin HY, et al. An Independent Risk of Gout on the Development of Deep Vein Thrombosis and Pulmonary Embolism: A Nationwide, Population-Based Cohort Study. Medicine (Baltimore). 2015;94(51): e2140.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1506_CR28","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acr.22469","volume":"67","author":"SP Juraschek","year":"2015","unstructured":"Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Gout, urate-lowering therapy, and uric acid levels among adults in the United States. Arthritis Care Res (Hoboken). 2015;67(4):588\u201392.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"20","key":"1506_CR29","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.21037\/atm-21-5052","volume":"9","author":"S Pang","year":"2021","unstructured":"Pang S, Jiang Q, Sun P, Li Y, Zhu Y, Liu J, et al. Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China. Ann Transl Med. 2021;9(20):1550.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1506_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette P, Clerson P, P\u00e9rissin L, Flipo RM, Bardin T. Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis. 2015;74(1):142\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1506_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/rheumatology\/kes253","volume":"52","author":"PC Robinson","year":"2013","unstructured":"Robinson PC, Merriman TR, Herbison P, Highton J. Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999\u20132009. Rheumatology (Oxford). 2013;52(1):118\u201326.","journal-title":"Rheumatology (Oxford)"},{"key":"1506_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2474-14-119","volume":"14","author":"E Roddy","year":"2013","unstructured":"Roddy E, Muller S, Hayward R, Mallen CD. The association of gout with sleep disorders: a cross-sectional study in primary care. BMC Musculoskelet Disord. 2013;14:119.","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"1506_CR33","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3899\/jrheum.141031","volume":"42","author":"N Schlesinger","year":"2015","unstructured":"Schlesinger N, Radvanski DC, Cheng JQ, Kostis JB. Erectile Dysfunction Is Common among Patients with Gout. J Rheumatol. 2015;42(10):1893\u20137.","journal-title":"J Rheumatol"},{"issue":"5","key":"1506_CR34","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar4281","volume":"15","author":"CA Scire","year":"2013","unstructured":"Scire CA, Manara M, Cimmino MA, Govoni M, Salaffi F, Punzi L, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):R101.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1506_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3899\/jrheum.200113","volume":"48","author":"R Te Kampe","year":"2021","unstructured":"Te Kampe R, Janssen M, van Durme C, Jansen TL, Boonen A. Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study. J Rheumatol. 2021;48(2):286\u201392.","journal-title":"J Rheumatol"},{"key":"1506_CR36","first-page":"423","volume":"12","author":"M Tee","year":"2020","unstructured":"Tee M, Lustre Ii C, Abrilla A, Afos IE, Ca\u00f1al JP. Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital. Res Rep Urol. 2020;12:423\u201331.","journal-title":"Res Rep Urol"},{"issue":"2","key":"1506_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5606\/ArchRheumatol.2017.6075","volume":"32","author":"Q Yu","year":"2017","unstructured":"Yu Q, Shen HC, Hu YC, Chen YF, Tung TH. Prevalence and Metabolic Factors of Hyperuricemia in an Elderly Agricultural and Fishing Population in Taiwan. Arch Rheumatol. 2017;32(2):149\u201357.","journal-title":"Arch Rheumatol"},{"key":"1506_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/CEG.S253619","volume":"13","author":"S Golmohammadi","year":"2020","unstructured":"Golmohammadi S, Tavasoli M, Asadi N. Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver. Clin Exp Gastroenterol. 2020;13:299\u2013304.","journal-title":"Clin Exp Gastroenterol"},{"issue":"4\u20136","key":"1506_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15257770.2013.853785","volume":"33","author":"NM Gonz\u00e1lez-Senac","year":"2014","unstructured":"Gonz\u00e1lez-Senac NM, Bail\u00e9n R, Torres RJ, de Miguel E, Puig JG. Metabolic syndrome in primary gout. Nucleosides Nucleotides Nucleic Acids. 2014;33(4\u20136):185\u201391.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"10","key":"1506_CR40","volume":"12","author":"M Irfan","year":"2020","unstructured":"Irfan M, Jawaid W, Hashmat O, Nisa Q, Khastoori DR 2nd, Shahbaz NN. Association Between Hyperuricemia and Acute Ischemic Stroke in Patients at a Tertiary Care Hospital. Cureus. 2020;12(10): e10899.","journal-title":"Cureus"},{"issue":"4","key":"1506_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/fampra\/cmg413","volume":"20","author":"HJ Janssens","year":"2003","unstructured":"Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract. 2003;20(4):413\u20136.","journal-title":"Fam Pract"},{"key":"1506_CR42","doi-asserted-by":"crossref","unstructured":"Kravchenko D, Bergner R, Behning C, Sch\u00e4fer VS. How to Differentiate Gout, Calcium Pyrophosphate Deposition Disease, and Osteoarthritis Using Just Four Clinical Parameters. Diagnostics (Basel) 2021; 11(6).","DOI":"10.3390\/diagnostics11060924"},{"issue":"10","key":"1506_CR43","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40618-015-0291-x","volume":"38","author":"XP Liao","year":"2015","unstructured":"Liao XP, Zhu HW, Zeng F, Tang ZH. The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy. J Endocrinol Invest. 2015;38(10):1075\u201382.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1506_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/hr.2013.137","volume":"37","author":"K Nagahama","year":"2014","unstructured":"Nagahama K, Inoue T, Kohagura K, Ishihara A, Kinjo K, Ohya Y. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa. Japan Hypertens Res. 2014;37(3):232\u20138.","journal-title":"Japan Hypertens Res"},{"issue":"6","key":"1506_CR45","first-page":"677","volume":"23","author":"MH Pillinger","year":"2017","unstructured":"Pillinger MH, Bangalore S, Klein AB, Baumgartner S, Morlock R. Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization. J Manag Care Spec Pharm. 2017;23(6):677\u201383.","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"1506_CR46","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1136\/ard.2010.130013","volume":"69","author":"G Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis. 2010;69(12):2090\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1506_CR47","doi-asserted-by":"publisher","first-page":"em270","DOI":"10.29333\/ejgm\/9297","volume":"18","author":"NLSLL Stepanova","year":"2021","unstructured":"Stepanova NLSLL. Hyperuricemia Predicts Residual Diuresis Decline in Peritoneal Dialysis Patients. Electr J Gen Med. 2021;18(1):em270.","journal-title":"Electr J Gen Med"},{"issue":"4","key":"1506_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5551\/jat.15727","volume":"20","author":"F Takeuchi","year":"2013","unstructured":"Takeuchi F, Yamamoto K, Isono M, Katsuya T, Akiyama K, Ohnaka K, et al. Genetic impact on uric acid concentration and hyperuricemia in the Japanese population. J Atheroscler Thromb. 2013;20(4):351\u201367.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"1506_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003095","volume":"17","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Taguchi I, Teragawa H, Ishizaka N, Kanzaki Y, Tomiyama H, et al. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial. PLoS Med. 2020;17(4): e1003095.","journal-title":"PLoS Med"},{"issue":"5","key":"1506_CR50","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3899\/jrheum.080487","volume":"36","author":"EQ Wu","year":"2009","unstructured":"Wu EQ, Patel PA, Mody RR, Yu AP, Cahill KE, Tang J, et al. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol. 2009;36(5):1032\u201340.","journal-title":"J Rheumatol"},{"issue":"8","key":"1506_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025528","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yang Y, Xue L, Wen J, Bo L, Tang M, et al. Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China. BMJ Open. 2019;9(8): e025528.","journal-title":"BMJ Open"},{"issue":"2","key":"1506_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2337\/dc07-1276","volume":"31","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31(2):361\u20132.","journal-title":"Diabetes Care"},{"key":"1506_CR53","doi-asserted-by":"crossref","unstructured":"Sluijs I, Beulens JW, van der AD, Spijkerman AM, Schulze MB, van der Schouw YT. Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. J Nutr 2013; 143(1):80-5.","DOI":"10.3945\/jn.112.167221"},{"issue":"9","key":"1506_CR54","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/dc09-0288","volume":"32","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737\u201342.","journal-title":"Diabetes Care"},{"issue":"2","key":"1506_CR55","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","volume":"26","author":"T Bardin","year":"2014","unstructured":"Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):186\u201391.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"1506_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"\u2022\u2022 Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137\u201349. This study reported that North America had the highest prevalence of diabetes from 1980 to 2013.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"1506_CR57","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00125-020-05253-x","volume":"63","author":"S Yuan","year":"2020","unstructured":"Yuan S, Larsson SC. An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study. Diabetologia. 2020;63(11):2359\u201371.","journal-title":"Diabetologia"},{"issue":"9945","key":"1506_CR58","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766\u201381.","journal-title":"Lancet"},{"issue":"1363","key":"1506_CR59","first-page":"39","volume":"125","author":"S Kumar","year":"2012","unstructured":"\u2022\u2022 Kumar S, Gupta R, Suppiah R. Gout in women: differences in risk factors in young and older women. N Z Med J. 2012;125(1363):39\u201345. A retrospective study showed that male patients with gout are more likely to be older than 50 years and use diuretics than female patients with gout.","journal-title":"N Z Med J"},{"issue":"8","key":"1506_CR60","first-page":"1582","volume":"31","author":"KL Wallace","year":"2004","unstructured":"\u2022\u2022 Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31(8):1582\u20137. An important study demonstrated that the prevalence of gout or uric acid increases with age.","journal-title":"J Rheumatol"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-023-01506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-023-01506-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-023-01506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T06:30:03Z","timestamp":1683181803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-023-01506-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1506"],"URL":"https:\/\/doi.org\/10.1007\/s11892-023-01506-2","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"18 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}